Cannabis Exports: SACHIDA Steps in to Assist Members with Offtake Agreements.
One of the issues South African cannabis exporters are struggling most with is securing offtake agreements for their crops. SACHIDA has stepped in to help fill this gap by offering qualifying members exclusive offtakes for key international markets.
Labat’s ‘Sweetheart Deal’ Confirmed as it Sells All Cannabis Assets to Former CEO Brian van Rooyen For No Cash Consideration
After months of speculation it’s now been confirmed that Labat’s former CEO Brian van Rooyen (pictured here) is behind the party buying the group’s cannabis assets. Labat signed the deal with van Rooyen on Friday 14 November in which his company All Trading Propriety, will take over CannAfrica, Sweetwaters and all other Labat cannabis interests in a ‘soft’ deal.
DTIC Committed to an Inclusive Commercialization Policy, Will Take Up Cannabis Arrests With SAPS
The DTIC is committed to open and transparent discussions with cannabis stakeholders and is engaging with the new minister of police to pull back on cannabis arrests. The new official in charge of driving cannabis policy for the DTIC, John Jeffery (pictured here) told Project Indlela webinar participants that the cannabis club model had merit and should be included in future legislation.
Project Indlela Webinar Key Outcome: Private Clubs and Legacy Communities Will Be Accommodated in Future Cannabis Laws
Project Indela’s inaugural webinar on Pathways to Legality was one of the most significant stakeholder engagements with Government this year. One of its main outcomes is that the DTIC is taking its compliance strategy seriously and has acknowledged that a cannabis commercialization policy must reflect the interests of private cannabis clubs and legacy cannabis communities. This all could come together in a national cannabis summit on 420 day next year.
Donors, Delays & Dirty Weed: How Aid Politics Strangled Cannabis Reform
Cannabis donors helping set up cannabis regulatory systems across the world are perpetuating the myth that they promote inclusivity. However, as guest contributor Lee Hymers’s research has shown, donor capital builds the walls of exclusion to enable corporate capital to buy the keys.
‘DTIC Hasn’t Learnt the Lessons of the Hemp Ban Fiasco, Should Release Cannabis Policy Regulations for Public Comment Now’
The Department of Trade, Industry and Competition’s approach to cannabis commercialization is similar to that of the Health Department when it issued its ill-considered hemp food ban. H3 Solutions Charl Botha writes that the DTIC is making the same mistake of developing key policy decisions without the broad consultation promised by the Presidency.
NYC: One Bird One Gram Pigeon Delivery Service Turns Out to Be Clickbait
An elaborate marketing stunt from a New York marijuana business evidently fooled more than a few media outlets into believing that carrier pigeons would soon be deployed to make cannabis deliveries throughout New York City. Turned out it was a ‘fake’ campaign, but it sure achieved its marketing objectives.
MG Health and Lucan Labs Lift Lesotho’s Export Game with Poland Providing EU GMP Certification
Lesotho’s main cannabis exporter MG Health and Maseru-based LuCan Labs are at the forefront of Lesotho’s bid to return to world cannabis markets after languishing in the doldrums over the past few years. The two companies are looking forward to opening new export markets, both having been awarded EU GMP certification via Polish authorities.
Labat Sets AGM for 2 December, Releases 2025 Results Confirming Dramatic Financial Recovery
Labat Africa has posted its annual financial results up to May 2025 showing a remarkable turnaround with a profit of R131 million compared to the previous year’s loss of R26 million. It has also announced that its AGM will be held on 2 December 2025.
New INCB Quotas Hint at Regulatory Divergence in Fast-growing Australian and German Markets
Australia and Germany are moving in opposite directions on cannabis imports, as both scramble to deal with the runaway growth of their medical cannabis markets. Their revisited import quotas indicate that there may be regulatory divergence developing between the two countries which South African exporters should be aware of.